tripalmitoyl cysteine has been researched along with B. burgdorferi Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heilbrun, M; Kirschning, CJ; Ma, Y; Philipp, MT; Wang, X; Weis, JH; Weis, JJ; Wooten, RM; Yoder, A | 1 |
1 other study(ies) available for tripalmitoyl cysteine and B. burgdorferi Infection
Article | Year |
---|---|
Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge.
Topics: Animals; Antibodies, Bacterial; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Cysteine; Lipoproteins; Lyme Disease; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Receptors, Cell Surface; Toll-Like Receptor 2; Toll-Like Receptors; Vaccination | 2003 |